Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TRILLION ENERGY’S WEST AKCAKOCA WELL ENTERS PRODUCTION (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Diagnamed Hldgs C.DMED

Alternate Symbol(s):  DGNMF

Healthcare
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its product includes BrainYear and BrainTremor.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:DMED)

Fundamentals Snapshot (CSE:DMED)

Current News (CSE:DMED)

DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product

GlobeNewswire 6 days ago

DiagnaMed Announces Application for OTCQB Listing

GlobeNewswire March 9, 2023

DiagnaMed Enters into License Agreement with University of Miami for Brain Health Platform for Integration with CERVAI(TM), a Brain Health AI Platform Leveraging Generative AI

GlobeNewswire February 22, 2023

DiagnaMed Prioritizes Development and Commercialization Initiatives for CERVAI(TM), a Brain Health AI Platform Leveraging Generative AI

GlobeNewswire February 14, 2023

DiagnaMed Announces Appointment of New Director

GlobeNewswire February 13, 2023

DiagnaMed Holdings (CSE:DMED) incorporates OpenAI's ChatGPT into its Brain Health Digital Platform

John Ballem  February 1, 2023

DiagnaMed Holdings Incorporates OpenAI's ChatGPT into BRAIN AGE(TM) AI Product Suite

GlobeNewswire February 1, 2023

DiagnaMed Holdings Provides Update for BRAIN AGE(TM) Development and Commercialization Milestones for 2023

GlobeNewswire January 31, 2023

DiagnaMed Holdings Acquires Exclusive Rights to a Virtual Reality and Artificial Intelligence-based Neurodiagnostic System for Neurodegenerative Disease

GlobeNewswire November 15, 2022
View More News ››

Opinion & Analysis (CSE:DMED)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:DMED)

DMED

And it has been done... 
Uptonothing - February 27, 2023

DMED

Going to .10 and beyond. Who's getting on the bus?
Uptonothing - February 15, 2023

DMED

Such an easy mover. 0.10 is easy goal for this stock. I'll keep taking cheap shares.
Uptonothing - December 8, 2022

DMED

Up up up
Uptonothing - November 24, 2022

DMED

Easy mover, push it 
Uptonothing - November 23, 2022
View more Bullboard ››

EasTower Wireless

EasTower Wireless

EasTower Wireless Inc is a U.S. provider of wireless communications infrastructure and related services.. The firm ...
View More »